Politics & Government

July 11, 2014 4:46 AM

What’s at stake as FDA mulls ‘off-label’ drug rules?

Should a pharmaceutical sales rep be allowed to tell a doctor that Topamax, a drug approved to treat seizures and prevent migraine headaches, might also help combat alcohol dependence? Or suggest the epilepsy drug Neurontin could also help treat bipolar disorders or insomnia? Or offer data showing that any number of other drugs could have uses beyond those listed on their labels?

Related content

Comments

Videos

More Videos

New species of bioluminescent jellyfish discovered, looks unreal 00:44

New species of bioluminescent jellyfish discovered, looks unreal

Watch: From hate to healing — A father's journey 03:50

Watch: From hate to healing — A father's journey

Funniest presidents of the last 25 White House Correspondents' Dinners 02:28

Funniest presidents of the last 25 White House Correspondents' Dinners

Campaign Ad: John Kasich calls himself 'Our Only Hope' 01:31

Campaign Ad: John Kasich calls himself 'Our Only Hope'

In Harnett, death by Taser 05:51

In Harnett, death by Taser

How prepared or unprepared for an earthquake are you? 01:41

How prepared or unprepared for an earthquake are you?

Dance helps D'Iberville boy overcome ADHD 02:17

Dance helps D'Iberville boy overcome ADHD

Dog attacks butterfly as horrified owner captures it on video 00:28

Dog attacks butterfly as horrified owner captures it on video

Target manager asked about bathroom policy 02:31

Target manager asked about bathroom policy

Share Video

Editor's Choice Videos